The PAH amyloid-like aggregates in PAH-R261Q mouse liver co-localize with autophagy markers such as P-p62 and LC3, which is a strong evidence of selective autophagy degradation of PAH-R261Q18. The gene discussed is MAP1LC3A; the disease is pulmonary arterial hypertension.